| Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2 V Monteil, H Kwon, P Prado, A Hagelkrüys, RA Wimmer, M Stahl, ... Cell 181 (4), 905-913. e7, 2020 | 2236 | 2020 |
| Tissue engineering by decellularization and 3D bioprinting E Garreta, R Oria, C Tarantino, M Pla-Roca, P Prado, F Fernandez-Aviles, ... Materials Today 20 (4), 166-178, 2017 | 262 | 2017 |
| Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells E Garreta, P Prado, C Tarantino, R Oria, L Fanlo, E Martí, D Zalvidea, ... Nature materials 18 (4), 397-405, 2019 | 219 | 2019 |
| The nuclear receptor ESRRA protects from kidney disease by coupling metabolism and differentiation P Dhillon, J Park, CH Del Pozo, L Li, T Doke, S Huang, J Zhao, HM Kang, ... Cell metabolism 33 (2), 379-394. e8, 2021 | 104 | 2021 |
| Non-coding microRNAs for cardiac regeneration: exploring novel alternatives to induce heart healing E Garreta, P Prado, JCI Belmonte, N Montserrat Non-coding RNA Research 2 (2), 93-99, 2017 | 6 | 2017 |
| Developing new strategies to understand human kidney development and target human disease PK Prado Peralta | | 2021 |
| Modelling the metabolic reprogramming of diabetic nephropathy using hESC-derived 3D kidney organoids C Hurtado del Pozo, E Laplaza, P Prado, A Gavalda-Navarro, E Garreta, ... DIABETOLOGIA 62, S30-S30, 2019 | | 2019 |
| Anàlisi de la morfologia i migració cel· lular en cèl· lules de tumors cerebrals malignes PK Prado Peralta | | 2015 |
